Physician profile
Daniel L Cavanaugh
NPI 1790004984
$245,855.90
in general payments reported to CMS, 2019-2025
17 companies · $40K in 2025
The $40K reported for 2025 was more than what 85% of Orthopaedic Surgery of The Spine providers received nationally (typical 2025 total: $2,116).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $6,686 · 2020: $4,637 · 2021: $66K · 2022: $65K · 2023: $34K · 2024: $30K · 2025: $40K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $73K · Travel and Lodging: $18K · Royalty Or License: $8,811 · Food and Beverage: $4,915.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $72,500.00 |
| Travel and Lodging | $17,552.61 |
| Royalty Or License | $8,811.17 |
| Food and Beverage | $4,915.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alphatec Spine, INC | $241,852.94 | 2019-2025 | Other - Miscellaneous, Identiti, Lif |
| Medtronic USA, INC. | $694.30 | 2019-2020 | |
| Nevro Corp. | $649.10 | 2020-2024 | Senza |
| Baxter Healthcare | $648.59 | 2021-2024 | Floseal |
| Sanara Medtech INC. | $574.64 | 2025 | Celleraterx |
| Medtronic, INC. | $555.00 | 2021-2024 | Medtronic Reusable Instruments |
| Boston Scientific Corporation | $296.53 | 2021 | |
| Stryker Corporation | $121.74 | 2020-2021 | |
| Nuvasive, INC. | $111.72 | 2023 | Tlif, Alif, Magec Spinal Bracing and Distraction System |
| International Rehabilitative Sciences, INC | $72.21 | 2024 | Rs 4i Plus Sequential Stimulator |
| Ethicon US, LLC | $66.24 | 2022-2025 | Dermabond Prineo, Stratafix |
| Arteriocyte Medical Systems, INC. | $61.38 | 2024 | Magellan |
| Electronic Waveform Lab, INC. | $61.33 | 2024-2025 | |
| Cerapedics INC. | $46.07 | 2022 | |
| Cmp Pharma, INC. | $20.74 | 2023 | Atorvaliq |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bioventus LLC | $15.39 | 2023 | Bonescalpel |
| Foundation Fusion Solutions, LLC | $7.98 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Cavanaugh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.